forbes.com/sites/robertglat...
Does anyone have more information on this?
forbes.com/sites/robertglat...
Does anyone have more information on this?
This came on today’s Medscape email. If you can’t open it let me know. It’s longish but I can do a copy and paste.
This was posted on Facebook yesterday:
(WCMH)--The U.S. Food and Drug Administration is voluntarily recalling a blood pressure medication after an impurity classified as a cancer-causing chemical was found.
According to the FDA, Losartan Potassium Hydrochlorothiazide Tablets, USP are indicated for the treatment of hypertension.
The recall includes 100 milligram/25 milligram tablets with the lot number JB8912.
CNN reports, the drug is being recalled because the active ingredient has tested positive for N-Nitrosodiethylamine, or NDEA, a suspected human and animal carcinogen that is used in gasoline as a stabilizer for industry materials and as a lubricant additive, according to the National Institutes of Health.
For more information or to report an issue with the medication click here.
If you clicked on the "click here", it takes you to this: fda.gov/Safety/Recalls/ucm6...
I think these are two different issues. The one you mention is related to a manufacturing recall. The one I’ve mentioned is a type of blood pressure medication demonstrating possible lung cancer affects.